Retinoblastoma screening

Jump to navigation Jump to search

Retinoblastoma Microchapters

Home

Patient Information

Overview

Historical perspective

Classification

Pathophysiology

Causes

Differentiating Retinoblastoma from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural history, Complications, and Prognosis

Diagnosis

Diagnostic Study of Choice

History & Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Retinoblastoma screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Retinoblastoma screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Retinoblastoma screening

CDC on Retinoblastoma screening

Retinoblastoma screening in the news

Blogs on Retinoblastoma screening

Directions to Hospitals Treating Retinoblastoma

Risk calculators and risk factors for Retinoblastoma screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2] Simrat Sarai, M.D. [3]

Overview

According to the United States Preventive Services Task Force, screening for retinoblastoma is not recommended in the general population. However, children with an increased risk of retinoblastoma such as those with a known 13q deletion or family history should be evaluated by an ophthalmologist shortly after birth. Dilated fundus examinations are recommended in siblings and offspring of patients with retinoblastoma.[1]

Screening

  • Children with a family history of retinoblastoma are at increased risk of developing retinoblastoma and require screening plan for the early diagnosis of the tumor.[2]
  • To schedule the screening plan, first, the risk of tumor development must be determined using the infant relationship to the family member with retinoblastoma.
  • The table below is an estimate of patients risk for the development of retinoblastoma depending on the relativity of patient to the affected relatives.
  • Risk of retinoblastoma development in the general population has been estimated at 0.007%.
Risk of carrying mutated gene in the relatives of a patient with retinoblastoma (Patient)(%)
Relative of patient Bilateral involvement (100%) Unilateral involvement (15%)
Offspring (infant) 50 7.5
Parent 5 0.8
Sibling 2.5 0.4
Niece/nephew 1.3 0.2
Aunt/uncle 0.1 0.007
First cousin 0.05 0.007
The above table adapted from Ophthalmology journal [3]

Next step in assessing the risk of these children is to estimate the approximate relative risk of retinoblatoma development according to the percentge mentioned in the afromentioned table.

  • Relatives are categorized into three categories:
    • High risk: those with risk percentage > 7.5%
    • Intermediate risk: those with risk percentage between and 1% and 7.5% (including 7.5%).
    • Low risk: those with risk percentage < 1%.

The following table is the recommended eye examination schedule for unaffected children of families with retinoblastoma depending on their age and risk percentage of tumor development.

Risk category or Age High risk Intermediate risk Low risk

Birth to 8 weeks

  • Every 2-4 weeks
  • Monthly
  • Monthly

>8-12 weeks

  • Monthly
  • Monthly
  • Monthly

>3 to 12 months

  • Monthly
  • Every 2 months
  • Every 3 months

>12 to 24 months

  • Every 2 months
  • Every 3 months
  • Every 4 months

>24 to 36 months

  • Every 3 months
  • Every 3 months
  • Every 6 months

>36 to 48 months

  • Every 4 months
  • Every 4-6 months
  • Every 6 months

>48 to 60 months

  • Every 6 months
  • Every 4-6 months
  • Annually

5 to 7 years

  • Every 6 months
  • Annually
  • Annually
The above table is the recommended management guideline for childhood screening of
families with affected individuals and adapted from Ophthalmology journal[3]

References

  1. Rothschild, P-R; Lévy, D; Savignoni, A; Lumbroso-Le Rouic, L; Aerts, I; Gauthier-Villars, M; Esteve, M; Bours, D; Desjardins, L; Doz, F; Lévy-Gabriel, C (2011). "Familial retinoblastoma: fundus screening schedule impact and guideline proposal. A retrospective study". Eye. 25 (12): 1555–1561. doi:10.1038/eye.2011.198. ISSN 0950-222X.
  2. Dhar, Shweta U. (2011). "Outcomes of Integrating Genetics in Management of Patients With Retinoblastoma". Archives of Ophthalmology. 129 (11): 1428. doi:10.1001/archophthalmol.2011.292. ISSN 0003-9950.
  3. 3.0 3.1 Skalet, Alison H.; Gombos, Dan S.; Gallie, Brenda L.; Kim, Jonathan W.; Shields, Carol L.; Marr, Brian P.; Plon, Sharon E.; Chévez-Barrios, Patricia (2018). "Screening Children at Risk for Retinoblastoma". Ophthalmology. 125 (3): 453–458. doi:10.1016/j.ophtha.2017.09.001. ISSN 0161-6420.